These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 17827463

  • 1. Chemoradiotherapy in malignant glioma: standard of care and future directions.
    Stupp R, Hegi ME, Gilbert MR, Chakravarti A.
    J Clin Oncol; 2007 Sep 10; 25(26):4127-36. PubMed ID: 17827463
    [Abstract] [Full Text] [Related]

  • 2. New chemotherapy options for the treatment of malignant gliomas.
    Soffietti R, Rudà R, Trevisan E.
    Anticancer Drugs; 2007 Jul 10; 18(6):621-32. PubMed ID: 17762390
    [Abstract] [Full Text] [Related]

  • 3. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
    Kortmann RD, Jeremic B, Weller M, Plasswilm L, Bamberg M.
    Strahlenther Onkol; 2003 Apr 10; 179(4):219-32. PubMed ID: 12707711
    [Abstract] [Full Text] [Related]

  • 4. Changing paradigms--an update on the multidisciplinary management of malignant glioma.
    Stupp R, Hegi ME, van den Bent MJ, Mason WP, Weller M, Mirimanoff RO, Cairncross JG, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group.
    Oncologist; 2006 Feb 10; 11(2):165-80. PubMed ID: 16476837
    [Abstract] [Full Text] [Related]

  • 5. Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents.
    Minniti G, Muni R, Lanzetta G, Marchetti P, Enrici RM.
    Anticancer Res; 2009 Dec 10; 29(12):5171-84. PubMed ID: 20044633
    [Abstract] [Full Text] [Related]

  • 6. O6-methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: frequency and time to tumor progression after alkylating agent-based chemotherapy.
    Silber JR, Blank A, Bobola MS, Ghatan S, Kolstoe DD, Berger MS.
    Clin Cancer Res; 1999 Apr 10; 5(4):807-14. PubMed ID: 10213216
    [Abstract] [Full Text] [Related]

  • 7. Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma.
    Yang SH, Hong YK, Yoon SC, Kim BS, Lee YS, Lee TK, Lee KS, Jeun SS, Kim MC, Park CK.
    Oncol Rep; 2007 Jun 10; 17(6):1359-64. PubMed ID: 17487391
    [Abstract] [Full Text] [Related]

  • 8. [Chemo-radiotherapy for malignant brain tumors].
    Kochi M, Ushio Y.
    Gan To Kagaku Ryoho; 2002 May 10; 29(5):669-76. PubMed ID: 12040669
    [Abstract] [Full Text] [Related]

  • 9. Does chemotherapy benefit the patient with a central nervous system glioma?
    Rodriguez LA, Levin VA.
    Oncology (Williston Park); 1987 Nov 10; 1(9):29-36, 40-1. PubMed ID: 3079493
    [Abstract] [Full Text] [Related]

  • 10. New developments in the treatment of malignant gliomas.
    Soffietti R, Leoncini B, Rudà R.
    Expert Rev Neurother; 2007 Oct 10; 7(10):1313-26. PubMed ID: 17939769
    [Abstract] [Full Text] [Related]

  • 11. Combined radio- and chemotherapy of brain tumours in adult patients.
    Nieder C, Mehta MP, Jalali R.
    Clin Oncol (R Coll Radiol); 2009 Sep 10; 21(7):515-24. PubMed ID: 19487112
    [Abstract] [Full Text] [Related]

  • 12. Molecular genetic markers as predictors of response to chemotherapy in gliomas.
    Idbaih A, Omuro A, Ducray F, Hoang-Xuan K.
    Curr Opin Oncol; 2007 Nov 10; 19(6):606-11. PubMed ID: 17906460
    [Abstract] [Full Text] [Related]

  • 13. Treatment options for malignant gliomas, emphasizing towards new molecularly targeted therapies.
    Argyriou AA, Antonacopoulou A, Iconomou G, Kalofonos HP.
    Crit Rev Oncol Hematol; 2009 Mar 10; 69(3):199-210. PubMed ID: 18602834
    [Abstract] [Full Text] [Related]

  • 14. Chemotherapy in the treatment of malignant gliomas.
    Stern JI, Raizer JJ.
    Expert Rev Anticancer Ther; 2006 May 10; 6(5):755-67. PubMed ID: 16759165
    [Abstract] [Full Text] [Related]

  • 15. The role of cytotoxic drugs in the treatment of central nervous system gliomas.
    Neyns B, D'haeseleer M, Rogiers A, Van de Cauter J, Chaskis C, Michotte A, Strik H.
    Acta Neurol Belg; 2010 Mar 10; 110(1):1-14. PubMed ID: 20514922
    [Abstract] [Full Text] [Related]

  • 16. Association between response to primary treatments and MGMT status in glioblastoma.
    Franceschi E, Tosoni A, Pozzati E, Brandes AA.
    Expert Rev Anticancer Ther; 2008 Nov 10; 8(11):1781-6. PubMed ID: 18983238
    [Abstract] [Full Text] [Related]

  • 17. Concurrent radiotherapy: fotemustine combination for newly diagnosed malignant glioma patients, a phase II study.
    Beauchesne PD, Taillandier L, Bernier V, Carnin C.
    Cancer Chemother Pharmacol; 2009 Jun 10; 64(1):171-5. PubMed ID: 19352662
    [Abstract] [Full Text] [Related]

  • 18. Exploring multi-targeting strategies for the treatment of gliomas.
    Omuro AM.
    Curr Opin Investig Drugs; 2008 Dec 10; 9(12):1287-95. PubMed ID: 19037835
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
    Felsberg J, Rapp M, Loeser S, Fimmers R, Stummer W, Goeppert M, Steiger HJ, Friedensdorf B, Reifenberger G, Sabel MC.
    Clin Cancer Res; 2009 Nov 01; 15(21):6683-93. PubMed ID: 19861461
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.